IntelliPharmaCeutics International Inc.

(IPCI:CA)

By |

Profile

IntelliPharmaCeutics International Inc is a pharmaceutical company. The Company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, pain. The company's lead product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval.

Contact Information

Website: www.intellipharmaceutics.com
Email: investors@intellipharmaceutics.com
Main Phone: +1 416 798-3001
Address: 30 Worcester Road
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M9W 5X2

Issuer Information

Exchange: TSX
CEO: Isa Odidi
Employees: 59
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

IntelliPharmaCeutics International Inc is a pharmaceutical company. The Company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, pain. The company's lead product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval.

Contact Information

Website: www.intellipharmaceutics.com
Email: investors@intellipharmaceutics.com
Main Phone: +1 416 798-3001
Address: 30 Worcester Road
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M9W 5X2

Issuer Information

Exchange: TSX
CEO: Isa Odidi
Employees: 59
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.29 $ -0.015 (-5.00%)
Last Price 0.29 Change $ -0.015 Change % -5.00 Tick N/A
Bid 0.29 Bid Size 27,000.00 Ask 0.30 Ask Size 10,000.00
Open 0.29 High 0.31 Low 0.29 Prev Close 0.30
Last Trade Volume 14,806 52 Wk Hi 7.20 52 Wk Low 0.20
Market Cap 6.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 22,075,577.00 EPS (TTM) -2.90 PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3.87 3.87 3.87 38.7
Low Target Price Estimate 3.12 3.12 3.12 31.2
Mean Target Price Estimate 3.5 3.5 3.5 34.95
Standard Deviation 0.53 0.53 0.53 5.3
Date of Most Recent Estimate 02/26/18 02/26/18 02/26/18 02/26/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1